Is ex vivo adenovirus mediated gene transfer a therapeutic option for the treatment of corneal diseases?

British Journal of Ophthalmology

Volumn 89, Issue 6, 2005, Pages 648-649

  Ritter, Thomas ^a,b   Gong, N ^a   Pleyer, U ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CAPSID PROTEIN;

CORNEA DISEASE; EDITORIAL; ENDOTHELIUM CELL; EPISOME; GENE DOSAGE; GENE EXPRESSION; GENE INSERTION; GENE TRANSFER; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS RECOMBINANT;

ADENOVIRIDAE; CORNEAL DISEASES; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS;

EID: 20344388074     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2005.065854     Document Type: Editorial

References (14)

1. Edelstein ML, Abedi MR, Wixon J, et al. Gene therapy clinical trials worldwide 1989-2004-an overview. J Gene Med 2004;6:597-602.
2. Anegon I, Guillonneau C, Hill M, et al. Application of gene transfer technologies to transplantation. (Review) Ther Drug Monit 2004;26:248-50.
3. Pleyer U, Dannowski H, Volk H-D, et al. Invited review: Corneal allograft rejection: current understanding. Ophmalmologica 2001;215:254-62.
4. George AJ, Larkin DF. Corned transplantation: the forgotten graft. (Review) Am J Transplant 2004;4:678-85.
5. Larkin DF, Oral HB, Ring O, et al. Adenovirus-mediated gene delivery to the corneal endothelium. Transplantation 1996;61:363-70.
6. Oral HB, Larkin DF, Fehervari Z, et al. Ex vivo adenovirus-mediated gene transfer and immunomodulatory protein production in human cornea. Gene Ther 1997;4:639-47.
7. Pleyer U, Bertelmann E, Rieck P, et al. Survival of corneal allografts following adenovirus-mediated gene transfer of interleukin-4. Graefes Arch Clin Exp Ophthalmol 2000;238:531-5.
8. Klebe S, Sykes PJ, Coster DJ, et al. Prolongation of sheep corneal allograft survival by ex vivo transfer of the gene encoding interleukin-10. Transplantation 2001;71:1214-20.
9. Bertelmann E, Ritter T, Vogt K, et al. Efficiency of cytokine gene transfer in corneal endothelial cells and organ cultured corneas mediated by liposomal vehicles and recombinant adenovirus. Ophthalmic Res 2003;35:117-24.
10. Qian Y, Leong FL, Kazlauskas A, et al. Ex vivo adenovirus-mediated gene transfer to corneal graft endothelial cells in mice. Invest Ophthalmol Vis Sci 2004;45:2187-93.
11. Rayner SA, Larkin DF, George AJ. TNF receptor secretion after ex vivo adenoviral gene transfer to cornea and effect on in vivo graft survival. Invest Ophthalmol Vis Sci 2001;42:1568-73.
12. Comer RM, King WJ, Ardjomand N, et al. Effect of administration of CTLA4Ig as protein or cDNA on corneal allograft survival. Invest Ophthalmol Vis Sci 2002;43:1095-103.
13. Ardjomand N, McAlister JC, Rogers NJ, et al. Modulation of costimulation by CD28 and CD154 alters the kinetics and cellular characteristics of corneal allograft rejection. Invest Ophthalmol Vis Sci 2003;44:3899-905.
14. Hudde T, Rayner SA, De Alwis M, et al. Adeno-associated and herpes simplex viruses as vectors for gene transfer to the corneal endothelium. Cornea 2000;19:369-73.